Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Peter J, Hoskin"'
Autor:
Tim A.D. Smith, Catharine M.L. West, Nuradh Joseph, Brian Lane, Joely Irlam-Jones, Elisabet More, Hitesh Mistry, Kimberley J. Reeves, Yee Pei Song, Mark Reardon, Peter J. Hoskin, Syed A. Hussain, Helen Denley, Emma Hall, Nuria Porta, Robert A. Huddart, Nick D. James, Ananya Choudhury
Publikováno v:
EBioMedicine, Vol 101, Iss , Pp 105032- (2024)
Summary: Background: BC2001 showed combining chemotherapy (5-FU + mitomycin-C) with radiotherapy improves loco-regional disease-free survival in patients with muscle-invasive bladder cancer (MIBC). We previously showed a 24-gene hypoxia-associated si
Externí odkaz:
https://doaj.org/article/d3a41a7a7af4450b80b677f0486387d4
Autor:
Andrea M. Fischer, Peter J. Hoskin
Publikováno v:
Radiation Oncology, Vol 17, Iss 1, Pp 1-7 (2022)
Abstract Introduction Acute and late toxicity was analysed for prostate cancer patients with bilateral hip prostheses, who received fixed field intensity modulated radiotherapy (IMRT). The aims were (1) to establish whether toxicity rates differed fr
Externí odkaz:
https://doaj.org/article/2ddb9e0420604385a56c6beb5f4ba940
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Externí odkaz:
https://doaj.org/article/7d34583d21194792872b29602e90c1e3
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 12, Iss 5, Pp 441-453 (2020)
Externí odkaz:
https://doaj.org/article/3f3ec49b6d4647f3b1226d8a3e91381a
Autor:
Jim Zhong, Finbar Slevin, Andrew F. Scarsbrook, Maria Serra, Ananya Choudhury, Peter J. Hoskin, Sarah Brown, Ann M. Henry
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundReirradiation using brachytherapy (BT) and external beam radiation therapy (EBRT) are salvage strategies with locally radiorecurrent prostate cancer. This systematic review describes the oncologic and toxicity outcomes for salvage BT and EB
Externí odkaz:
https://doaj.org/article/35086dde3c4c44c6b24dbccd73d23820
Autor:
Peter J Hoskin
Radioisotope therapy is an internal form of radiation used to treat cancer; it may be administered orally or intravenously and represents the nearest treatment option to the'magic bullet', specifically targeting sites of disease whilst sparing surrou
Autor:
Lingjian Yang, Darren Roberts, Mandeep Takhar, Nicholas Erho, Becky A.S. Bibby, Niluja Thiruthaneeswaran, Vinayak Bhandari, Wei-Chen Cheng, Syed Haider, Amy M.B. McCorry, Darragh McArt, Suneil Jain, Mohammed Alshalalfa, Ashley Ross, Edward Schaffer, Robert B. Den, R. Jeffrey Karnes, Eric Klein, Peter J. Hoskin, Stephen J. Freedland, Alastair D. Lamb, David E. Neal, Francesca M. Buffa, Robert G. Bristow, Paul C. Boutros, Elai Davicioni, Ananya Choudhury, Catharine M.L. West
Publikováno v:
EBioMedicine, Vol 31, Iss , Pp 182-189 (2018)
Background: Hypoxia is associated with a poor prognosis in prostate cancer. This work aimed to derive and validate a hypoxia-related mRNA signature for localized prostate cancer. Method: Hypoxia genes were identified in vitro via RNA-sequencing and c
Externí odkaz:
https://doaj.org/article/d7a28abff5b84473b106469a00a0c343
Autor:
Peter J. Hoskin, Kirsten Hopkins, Vivek Misra, Tanya Holt, Rhona McMenemin, Fiona McKinna, Krishnaswamy Madhavan, Andrew Bates, Noelle O'Rourke, Jason F. Lester, Tim Sevitt, Daniel Roos, Gillian Brown, Sharon Shibu Thomas, Sharon Forsyth, Krystyna Reczko, Allan Hackshaw, Catherine O'Hara, Andre Lopes
Publikováno v:
Radiotherapy and Oncology. 173:77-83
Metastatic spinal cord compression (MSCC) carries a poor prognosis and management is based on the likelihood of maintaining mobility and predicted survival.SCORAD is a randomised trial of 686 patients comparing a single dose of 8 Gy radiotherapy with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::604351d1149a169e1b14dd01a1764953
https://doi.org/10.1016/j.radonc.2022.05.017
https://doi.org/10.1016/j.radonc.2022.05.017
Autor:
Catharine M.L. West, Johannes H.A.M. Kaanders, Adrian L. Harris, Francesca M. Buffa, Peter J. Hoskin, Ana M. Rojas, Jarrod J. Homer, Crispin J. Miller, Helen Denley, Guy N.J. Betts, Janet Taylor, Joely J. Irlam, Paul N. Span, Navin Mani, Amanda Eustace
Supplementary data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a2a54d6f1972363229a55ea31deee62
https://doi.org/10.1158/1078-0432.22447830
https://doi.org/10.1158/1078-0432.22447830
Autor:
Catharine M.L. West, Ananya Choudhury, Adrian L. Harris, Francesca M. Buffa, Jan Alsner, Peter J. Hoskin, Helen Denley, Joely J. Irlam, Amanda Eustace, Janet Taylor, Lingjian Yang
Purpose: Hypoxia modification improves overall survival in muscle-invasive bladder cancer patients who undergo radiotherapy. There is evidence that hypoxic tumors benefit most from hypoxia modification. The study aimed to identify or derive a hypoxia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ec3d6aba53558689d237b4d4daee602
https://doi.org/10.1158/1078-0432.c.6525131
https://doi.org/10.1158/1078-0432.c.6525131